Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has 6 years of Operating Leases data on file, last reported at $2000.0 in Q4 2024.

• Operating Leases for Q4 2024 came in at $2000.0, down 99.88% year-over-year; the trailing twelve-month figure through Dec 2024 was $2000.0 (down 99.88% YoY), and the FY2024 annual result was $2000.0, down 99.88% from the prior year.
• Operating Leases slipped to $2000.0 in Q4 2024 per IRMD's latest filing, from $2831.0 in the prior quarter.
• Over five years, Operating Leases peaked at $2.7 million in Q1 2020 and troughed at $2000.0 in Q4 2024.
• A 5-year average of $1.8 million and a median of $2.0 million in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2020 and 2024: Operating Leases decreased 8.44% in 2020, then tumbled 99.88% in 2024.
• A 5-year view of Operating Leases shows it stood at $2.5 million in 2020, then retreated by 10.32% to $2.2 million in 2021, then fell by 13.32% to $1.9 million in 2022, then slipped by 15.52% to $1.6 million in 2023, then plunged by 99.88% to $2000.0 in 2024.
• Business Quant data shows IRMD's Operating Leases at $2000.0 in Q4 2024, $2831.0 in Q3 2024, and $4231.0 in Q2 2024.